M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease? (2020)

First Author: Scarpa M
Attributed to:  Targeting the M4 muscarinic acetylcholine receptor in neurodegenerative disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/bs.apha.2019.12.003

PubMed Identifier: 32416870

Publication URI: http://europepmc.org/abstract/MED/32416870

Type: Journal Article/Review

Volume: 88

Parent Publication: Advances in pharmacology (San Diego, Calif.)

ISSN: 1054-3589